Stanford researchers have developed a novel technology using extracellular vesicles (EVs) to selectively suppress immune responses to AAV vectors, enabling safer and more effective gene therapy.
Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.
Researchers in the Wyss-Coray Lab are investigating a potential therapeutic antibody to treat lysosomal storage disorders and other related neurodegenerative diseases.
Stanford researchers have developed an innovative, non-invasive therapeutic strategy to treat myocardial fibrosis (MF), a key driver of arrhythmia and heart failure in LMNA-related dilated cardiomyopathy (LMNA-DCM).
Stanford researchers have developed Screen-GPT, an AI-powered multi-agent platform that automates CRISPR genetic screening by integrating diverse biological data to design libraries and prioritize targets through transparent, explainable, and scalable workflows.
Stanford researchers in the Cochran Lab have patented a potential pancreatic cancer therapeutic approach using novel agents that bind tightly to and inhibit a cancer factor called LIF (leukemia inhibitory factor).
Stanford researchers have developed a novel RNA-targeting therapeutic platform using CRISPR-Cas13d to selectively degrade oncogenic mRNA associated with uveal melanoma (UM), an aggressive and treatment-resistant form of eye cancer.
Stanford scientists have developed innovative methods for safely collecting, preserving, imaging, and molecularly profiling human brain tissue that remains on explanted intracranial electrodes used in neurosurgical procedures.
SARS-CoV2 is known to gain entry into epithelial cells through the association of its viral spike protein with the ACE2 receptor, which is widely expressed on epithelial cell types.
Stanford researchers developed an electrochemical reactor process that combines electrodialysis and membrane stripping, reduces the chemical inputs needed and expands recovered product portfolio to alkaline ammonia (for cleaning products) in ratios customized to a user's speci
Stanford researchers have developed an Electrodialysis and Nitrate Reduction Process (EDNR) that produces high-purity ammonia from agricultural runoff.
Stanford researchers have developed an "electrocatalyst-in-a-box" that extracts wastewater nitrate and converts it into ammonia. Nitrogen pollution threatens water security and human health, and demand for ammonia continues to grow.